MARK WELTON, the President IMAX Global Theatres of $IMAX, sold 49,504 shares of the company on 11-10-2025 for an estimated $1,743,926. We received data on the trade from a recent SEC filing. This was a sale of approximately 24.4% of their shares of this class of stock. Following this trade, they now own 153,323 shares of this class of $IMAX stock.
$IMAX Insider Trading Activity
$IMAX insiders have traded $IMAX stock on the open market 9 times in the past 6 months. Of those trades, 0 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $IMAX stock by insiders over the last 6 months:
- RICHARD L GELFOND (Chief Executive Officer) sold 100,000 shares for an estimated $2,711,440
- ROBERT D LISTER (Chief Legal Officer Sr Exec VP) has made 0 purchases and 2 sales selling 70,143 shares for an estimated $2,394,217.
- MARK WELTON (President IMAX Global Theatres) sold 49,504 shares for an estimated $1,743,926
- CALAMERA PABLO (CTO & EVP) sold 20,586 shares for an estimated $704,566
- KENNETH IAN WEISSMAN (Deputy GC, Corp. Sec. & CCO) has made 0 purchases and 2 sales selling 15,072 shares for an estimated $386,560.
- GIOVANNI M. DOLCI (Chief Commercial Officer & EVP) has made 0 purchases and 2 sales selling 12,688 shares for an estimated $374,377.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$IMAX Hedge Fund Activity
We have seen 98 institutional investors add shares of $IMAX stock to their portfolio, and 105 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ORBIS ALLAN GRAY LTD added 1,230,267 shares (+31.7%) to their portfolio in Q2 2025, for an estimated $34,398,265
- J. GOLDMAN & CO LP removed 648,332 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $18,127,362
- FMR LLC removed 609,311 shares (-12.2%) from their portfolio in Q2 2025, for an estimated $17,036,335
- WELLINGTON MANAGEMENT GROUP LLP added 535,788 shares (+inf%) to their portfolio in Q2 2025, for an estimated $14,980,632
- GOLDMAN SACHS GROUP INC added 488,086 shares (+154.0%) to their portfolio in Q2 2025, for an estimated $13,646,884
- BALYASNY ASSET MANAGEMENT L.P. added 449,497 shares (+inf%) to their portfolio in Q2 2025, for an estimated $12,567,936
- D. E. SHAW & CO., INC. added 401,950 shares (+271.3%) to their portfolio in Q2 2025, for an estimated $11,238,522
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$IMAX Analyst Ratings
Wall Street analysts have issued reports on $IMAX in the last several months. We have seen 6 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barrington Research issued a "Outperform" rating on 10/24/2025
- Rosenblatt issued a "Buy" rating on 10/24/2025
- Wells Fargo issued a "Overweight" rating on 10/24/2025
- Roth Capital issued a "Buy" rating on 10/14/2025
- Wedbush issued a "Outperform" rating on 09/22/2025
- Benchmark issued a "Buy" rating on 07/25/2025
To track analyst ratings and price targets for $IMAX, check out Quiver Quantitative's $IMAX forecast page.
$IMAX Price Targets
Multiple analysts have issued price targets for $IMAX recently. We have seen 7 analysts offer price targets for $IMAX in the last 6 months, with a median target of $39.0.
Here are some recent targets:
- Patrick Sholl from Barrington Research set a target price of $37.0 on 10/24/2025
- David Karnovsky from JP Morgan set a target price of $32.0 on 10/24/2025
- Omar Mejias from Wells Fargo set a target price of $40.0 on 10/24/2025
- Steve Frankel from Rosenblatt set a target price of $42.0 on 10/24/2025
- Eric Handler from Roth Capital set a target price of $40.0 on 10/14/2025
- Alicia Reese from Wedbush set a target price of $39.0 on 09/22/2025
- Mike Hickey from Benchmark set a target price of $32.0 on 07/25/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
